(Q54333758)

27 May 2018

title

DNA damage and cytotoxicity of mitoxantrone and doxorubicin in doxorubicin-sensitive and -resistant human colon carcinoma cells. (English)

1 reference

27 May 2018

0 references

0 references

1 reference

3

1 reference

27 May 2018

author name string

L Capolongo

series ordinal

1

1 reference

27 May 2018

G Belvedere

series ordinal

2

1 reference

27 May 2018

publication date

1 January 1990

1 reference

27 May 2018

Cancer Chemotherapy and Pharmacology

published in

1 reference

27 May 2018

volume

25

1 reference

27 May 2018

issue

6

1 reference

27 May 2018

page(s)

430-434

1 reference

27 May 2018

Direct relation of DNA lesions in multidrug-resistant human myeloma cells to intracellular doxorubicin concentration.

cites work

1 reference

12 December 2020

Comparison of intracellular drug retention, DNA damage and cytotoxicity of derivatives of doxorubicin and daunorubicin in a human colon adenocarcinoma cell line (LoVo)

1 reference

12 December 2020

Anthracycline-induced DNA breaks and resealing in doxorubicin-resistant murine leukemic P388 cells.

1 reference

12 December 2020

Interactions of the antitumor agents mitoxantrone and bisantrene with deoxyribonucleic acids studied by electron microscopy

1 reference

12 December 2020

Doxorubicin cellular pharmacokinetics and DNA breakage in a multi-drug resistant B16 melanoma cell line.

1 reference

12 December 2020

Intracellular doxorubicin concentrations and drug-induced DNA damage in a human colon adenocarcinoma cell line and in a drug-resistant subline.

1 reference

12 December 2020

Relationship between cytotoxicity and DNA damage in mammalian cells treated with anthracenedione derivatives

1 reference

12 December 2020

Clinical safety and tolerance of mitoxantrone

1 reference

12 December 2020

Mitoxantrone, vincristine, and prednisone in adults with relapsed or primarily refractory acute lymphocytic leukemia and terminal deoxynucleotidyl transferase positive blastic phase chronic myelocytic leukemia.

1 reference

12 December 2020

Establishment of a human carcinoembryonic antigen-producing colon adenocarcinoma cell line

1 reference

12 December 2020

Antitumor activity of mitoxantrone against murine experimental tumors: comparative analysis against various antitumor antibiotics

1 reference

12 December 2020

Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II

1 reference

12 December 2020

A clinical and pharmacokinetic study of mitoxantrone in acute nonlymphocytic leukemia

1 reference

12 December 2020

Identification of anthracycline analogues with enhanced cytotoxicity and lack of cross-resistance to adriamycin using a series of mammalian cell lines in vitro.

1 reference

12 December 2020

Design of anticancer drugs using modeling techniques

1 reference

12 December 2020

Anthracenedione activation by nadph-cytochrome p-450 reductase; Comparison with anthracyclines

1 reference

12 December 2020

Reduction of adriamycin to a semiquinone-free radical by NADPH cytochrome P-450 reductase produces DNA cleavage in a reaction mediated by molecular oxygen

1 reference

12 December 2020

Cellular discriminants for a biological classification of human colon carcinoma

1 reference

12 December 2020

Comparative molecular pharmacology in leukemic L1210 cells of the anthracene anticancer drugs mitoxantrone and bisantrene

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00686054

1 reference

27 May 2018

1 reference

27 May 2018